|
||
| ||||||||||||||||||||||||||
Index of Online Supplemental Material for
J. Cell Biol. 10.1083/jcb.200312168
Berdeaux et al.
Figure S1 Both dominant negative and constitutively active Rho inhibit protease secretion induced by oncogenic Src.
Figure S2 Constitutively active Rho is specifically recognized by in situ Rho[GTP] affinity assays.
Figure S3 Endogenous active Rho is specifically detected by in situ Rho[GTP] affinity assays.
| ||||||||||||||||||||||||||
|
|